Table 4.
Detailed criteria of models based on radiology studies.
| Author (Year) |
Criteria |
|---|---|
| [63] (2014) |
9 criteria: 3 clinical criteria (age ≥ 60 years, CA-125 ≥ 500 U/mL, American Society of Anesthesiologists [ASA] class ≥3) and 6 radiologic criteria (>1 cm lesions in the small bowel mesentery; >1 cm lesions in the root of the superior mesenteric artery; >1 cm lesions in the perisplenic area; >1 cm lesions in the lesser sac; >1 cm suprarenal retroperitoneal lymph nodes; and diffuse small bowel adhesions/thickening). |
| [64] (2017) |
11 criteria: 3 clinical criteria (age ≥ 60 years, CA-125 ≥ 600 U/mL, American Society of Anesthesiologists (ASA) class-≥3) and 8 radiologic criteria (>1 cm lesions in the root of the superior mesenteric artery; >1 cm lesions in the splenic hilum/ligaments; >1 cm retroperitoneal lymph nodes above the renal hilum including supradiaphragmatic lymph nodes; >1 cm lesser sac lesions; diffuse small bowel adhesions/thickening; moderate-severe abdominal ascites; lesions on gastrohepatic ligament/porta hepatis; and gallbladder fossa/intersegmental fissure lesions). |
| [66] (2018) |
Scoring parameters: CA-125 level (≥500 U/mL); performance status of ≥2; large-volume ascites; omentum disease extension to the stomach, spleen or lesser sac; tumor extension to the pelvic sidewall, parametria or hydroureter; peritoneal thickening; ≥2 cm peritoneal implants; ≥1 cm suprarenal paraaortic lymph nodes; ≥2 cm diaphragm or lung base disease or confluent plaques; ≥2 cm inguinal canal disease or lymph nodes; ≥2 cm liver lesion on the surface or any size parenchymal lesion; porta hepatis or ≥1 cm gallbladder fossa disease; ≥2 cm infrarenal paraaortic lymph nodes; and ≥2 cm small or large bowel mesentery disease |
| [67] (2005) |
Preoperative inoperable cancer sites: >2 cm of peritoneal implants in lesser sac, gall bladder fossa, gastrosplenic ligament, gastrohepatic ligament, root of the small bowel mesentery, subphrenic space, intersegmental fissure or porta hepatis; >2 cm of retroperitoneal adenopathy above the renal hilum; abdominal wall incursion; or hepatic metastases |